4.6 Review

Extracellular Vesicles as Biomarkers in Cardiovascular Disease; Chances and Risks

Journal

FRONTIERS IN CARDIOVASCULAR MEDICINE
Volume 5, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2018.00113

Keywords

microparticle; atherosclerosis; vascular remodeling; diagnostic; platelet; endothelial cell; monocyte

Funding

  1. European Union [722609]
  2. Netherlands Foundation for Scientific Research [ZonMW VIDI 016.126.358]
  3. Landsteiner Foundation for Blood Transfusion Research (LSBR) [1638]
  4. Deutsche Forschungsgemeinschaft [SFB1123/A2]

Ask authors/readers for more resources

The field of extracellular vesicles (EV) is rapidly expanding, also within cardiovascular diseases. Besides their exciting roles in cell-to-cell communication, EV have the potential to serve as excellent biomarkers, since their counts, content, and origin might provide useful information about the pathophysiology of cardiovascular disorders. Various studies have already indicated associations of EV counts and content with cardiovascular diseases. However, EV research is complicated by several factors, most notably the small size of EV. In this review, the advantages and drawbacks of EV-related methods and applications as biomarkers are highlighted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available